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T
he world of emerging infec-
tions lost a valuable friend 
and inspiring leader earlier this 
year with the death of Joshua Le-
derberg. The globally recognized 
scientist, educator, national and 
Presidential scientiﬁ  c  advisor, 
and Nobel Laureate died of pneu-
monia on February 2, 2008, at the 
age of 82. Dr Lederberg’s early 
work on bacterial genetics virtu-
ally established the discipline of 
molecular biology, earning him 
a Nobel Prize in Physiology or 
Medicine in 1958, when he was only 33 years of age. His 
contributions paved the way toward understanding micro-
bial adaptation, including the development of antimicrobial 
drug resistance and the implications of these evolutionary 
changes for clinical medicine and public health. Equally 
impressive are his public service contributions; he served 
as a science advisor to 9 US presidents.
Dr Lederberg began his exploration of bacterial ge-
netics as a doctoral student at Yale University, where he 
forged new paths and gained prominence in the developing 
ﬁ  eld. Over the next 30 years, he held academic posts and 
chaired new genetics departments at the University of Wis-
consin and Stanford University. In 1978, he joined Rock-
efeller University as its president. Over the next 12 years, 
his accomplishments and successes in this position were a 
testimony to his scholarly accomplishments and leadership 
skills; he remained afﬁ  liated with the university for the rest 
of his life. He offered science policy advice not only to 
9 US administrations but also to the National Aeronautics 
and Space Administration and the Department of Defense. 
In addition to the Nobel Prize, his numerous prestigious 
awards included the National Medal of Science in 1989 and 
the Presidential Medal of Freedom in 2006.
To those of us working in the ﬁ  eld of emerging infec-
tious diseases, Dr Lederberg will be most remembered for 
his critical role in recognizing the threats posed by emerging 
and reemerging infections and their implications for public 
health and national security. He is well known to readers of 
Emerging Infectious Diseases (EID) as a contributor to the 
journal (1,2) and for his leadership as co-chair with the late 
Robert Shope (3) of the Institute of Medicine (IOM) Com-
mittee on Emerging Microbial Threats to Health, which 
produced the 1992 report Emerging Infections: Microbial 
Threats to Health in the United States (4) (Figure 1, panel 
A). This landmark report deﬁ  ned the concept of emerging 
and reemerging infections, identiﬁ  ed factors contributing 
to disease emergence and reemergence, and emphasized 
current and future challenges posed by infectious diseases. 
The report also highlighted deﬁ   ciencies in our nation’s 
public health infrastructure and made recommendations on 
the need to strengthen surveillance systems, address new 
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Figure 1. A) Emerging Infections: Microbial Threats to Health in 
the United States (4), a report of the Institute of Medicine (IOM) 
Committee on Emerging Microbial Threats to Health, published 
in 1992. B) Microbial Threats to Health: Emergence, Detection, 
and Response (8), a report of the IOM Committee on Emerging 
Microbial Threats to Health, published in 2003.
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Dr Lederbergareas of research, provide multidisciplinary training for the 
next generation of scientists and public health workers, and 
establish new and enhance existing disease prevention and 
control programs. EID owes its genesis to this report.
Drs Lederberg and Shope were extremely effective 
in communicating the committee’s observations and rec-
ommendations to the scientiﬁ  c, public health, and public 
policy communities, generating broad and renewed interest 
in infectious diseases. The report had a profound impact on 
the Centers for Disease Control and Prevention (CDC), the 
National Institute of Allergy and Infectious Diseases, the 
Department of Defense, and other federal agency programs 
involved in addressing emerging infectious disease threats. 
The report’s emphasis on the need for interdisciplinary 
strategies and coordinated approaches led to the establish-
ment of the Working Group on Emerging and Re-emerging 
Infectious Diseases under the auspices of the National Sci-
ence and Technology Council Committee on Internation-
al Science, Engineering and Technology. This Working 
Group was chaired by CDC Director David Satcher, and 
its deliberations led to vastly improved communication and 
collaboration among many federal agencies (5). 
For CDC, the impact of the IOM report and Dr Leder-
berg’s contributions were substantial. CDC worked with 
partners to develop new domestic and global strategies 
to address emerging infections, including speciﬁ  c efforts 
to respond to the IOM recommendations. Dr Lederberg 
served as an advisor on the development of these strate-
gies (Figure 2), the ﬁ  rst of which was published in 1994 
(6), with an update 4 years later (7). From 1994 through 
2004, CDC’s funding for infectious diseases grew nearly 
200-fold, from $1 million to >$190 million, enabling de-
velopment and implementation of numerous programs to 
build epidemiology and laboratory capacity and improve 
preparedness and response capacity for infectious diseas-
es and other health threats. Examples of these programs 
include the Emerging Infections Programs with activities 
such as FoodNet and Active Bacterial Core surveillance; 
the International Emerging Infections Programs; the Epi-
demiology and Laboratory Capacity for Infectious Dis-
eases cooperative agreement; the Emerging Infectious 
Diseases Laboratory Fellowship Program; this journal; 
and the International Conference on Emerging Infectious 
Diseases, ﬁ  rst held in 1998 with Dr Lederberg serving as 
the inaugural plenary speaker (2) and, most recently, in 
March 2008.
As an advocate for improvements in information sys-
tems and transparency, Dr Lederberg enthusiastically sup-
ported innovative approaches that included the establish-
ment of ProMED and the Global Public Health Information 
Network. Internationally, he served as an advisor to the 
World Health Organization (WHO) on the creation of its 
Emerging Infections Program and personally advocated the 
need for establishing this program with WHO’s then direc-
tor general, Dr Hiroshi Nakajima.
Dr Lederberg also served as co-chair, with Dr Marga-
ret Hamburg, of a second IOM committee that produced a 
follow-up to the 1992 report. Microbial Threats to Health: 
Emergence, Detection, and Response was published in 
March 2003 (8), less than 1 week after WHO issued its ﬁ  rst 
global health alert in response to the outbreak of severe acute 
respiratory syndrome (SARS). This report had a broader 
global perspective than the 1992 report and identiﬁ  ed ad-
ditional factors contributing to disease emergence, reemer-
gence, and global spread. The report also anticipated many 
issues that the 2003 SARS outbreak so starkly illustrated, 
including the need for increased collaboration among the hu-
man and animal health communities, a recommendation now 
supported by the One Health Initiative (9). The 2003 report’s 
cover (Figure 1, panel B) depicts an artistic rendering of in-
ﬂ  uenza virus, reﬂ  ecting Dr Lederberg’s longstanding inter-
est in inﬂ  uenza research and his concern about national and 
global preparedness for the next pandemic.
As a charter member of the IOM, Dr Lederberg was the 
driving force behind the creation of its Forum on Emerging 
Infections (now the Forum on Microbial Threats), steering 
it effectively as chairperson through 2002. Consistent with 
his approach, the forum comprises representatives of the 
medical, academic, public health, veterinary, agricultural, 
environmental, national security, and pharmaceutical sec-
tors. An important part of his legacy, the forum continues 
to address a broad range of issues in an interdisciplinary 
setting on a regular basis, recently focusing on vector-
borne and zoonotic diseases and the potential impact of 
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Figure 2. Institute of Medicine co-chair Joshua Lederberg (left) in 
conversation with James M. Hughes, director, National Center for 
Infectious Diseases, Centers for Disease Control and Prevention 
(CDC), during a meeting in 1993 with expert consultants on 
development of the ﬁ   rst CDC emerging infectious disease 
strategy.In Memoriam: Joshua Lederberg (1925–2008)
climate change on infectious diseases. As Josh liked to 
say, there is an ongoing confrontation with the microbial 
world involving “our wits versus their genes.” The forum 
held a workshop in May 2008 on microbial evolution and 
coadaptation in honor of Dr Lederberg (www.iom.edu/
CMS/3783/3924/52347.aspx).
On a personal level, I (J.M.H.) ﬁ  rst encountered Pro-
fessor Lederberg in the late 1960s, when I was a medical 
student and he was the chairman of the Genetics Depart-
ment at Stanford. His stature and accomplishments were 
legendary, and we were in awe of him. Over the course 
of my CDC career, I was fortunate to have many interac-
tions with Josh and to greatly beneﬁ  t from his insightful 
questions, keen observations, and constructive comments. 
He was very approachable and consistently available to 
discuss a broad range of issues, having an uncanny ability 
to readily span from basic science, to applied science, to 
public health, to policy, and to national security. He was a 
mentor, friend, and colleague to many.
For me (D.P.D.), Dr Lederberg was a great friend and 
early champion of EID, supporting the journal from its ﬁ  rst 
issue in 1995. He helped us obtain credibility by recruit-
ing editorial board members, supporting our application for 
early listing in national databases, and encouraging authors 
and reviewers of the nascent journal. We proﬁ  led him brief-
ly when we published his plenary lecture at the inaugural 
International Conference on Emerging Infectious Diseases 
(Figure 3) (2) and compared his far-seeing work to that of 
Rudolf Virchow, one of the founders of modern medical 
science, because both wrote reports that called the attention 
of central governments to the manifold contributors to the 
web of causation of emerging diseases (10).
Dr Lederberg will be remembered for his scientiﬁ  c vi-
sion and contributions, his integrity and credibility, and his 
unwavering commitment to advocate for the highest qual-
ity science and evidence-based public policy. He was a ﬁ  rm 
believer in the need for scientists and public health ofﬁ  cials 
to communicate clearly and concisely with policy makers 
and the public on scientiﬁ  c and public health issues. His 
inﬂ  uence and impact reached broadly, across areas of ex-
pertise and around the world. He will be greatly missed.
Dr Hughes is professor of medicine in the Division of Infec-
tious Diseases, Department of Medicine, School of Medicine, and 
professor of public health in the Hubert Department of Global 
Health, Rollins School of Public Health, at Emory University.   
His research interests include factors contributing to infectious 
disease emergence and antimicrobial resistance; global infectious 
disease surveillance and public health capacity building; and wa-
ter-related diseases and the impact of water, sanitation, and hand 
hygiene interventions on health.
Dr Drotman is editor-in-chief of the journal Emerging Infec-
tious Diseases at CDC.  
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Figure 3. Keynote speakers at the inaugural International 
Conference on Emerging Infectious Diseases in Atlanta, March 
8–11, 1998. Left to right: Anthony Fauci, David Heymann, Joshua 
Lederberg, Claire Broome, James Hughes, Guthrie Birkhead, D. 
Peter Drotman.